Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#258 Diagnosis and Management of Thymic Neuroendocrine Tumors: A Case Series Review

Introduction: Thymic neuroendocrine tumors (TNET) represent rare types of thymic tumors with an incidence of 0.01/100000 per year. They commonly show rapid disease progression and are rarely curable.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Akay E, El-Khouly F, Khan M, Caplin M, Toumpanakis C,

Keywords: thymic, thymic neuroendocrine tumor, radical thymectomy, chemotherapy, somatostatin analogues, Y-90,

#252 Y90-DOTATATE in Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Survival Following Different Indications for Treatment

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an increasingly used treatment for GEP -NETs but there is limited data on indications, efficacy and survival.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Khan M, El-Khouly F, Quigley A, Caplin M, Toumpanakis C,

Keywords: neuroendocrine tumor, radionuclides, survival, therapy,

#251 Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors

Introduction: The recent classification system proposed by ENETS assigns grade by Ki-67 index +/- mitotic count. It has been adopted into routine practice but there is limited data on the relationship between them.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Khan M, El-Khouly F, Toumpanakis C, Meyer T, Caplin M,

Keywords: survival, neuroendocrine tumor, Ki-67, proliferation, biomarker,

#244 Challenges in the Management of VIPoma Patients

Introduction: VIPomas are a rare neuroendocrine tumor (NET). 90% are pancreatic. 40-70% are metastatic at presentation. The VIPoma syndrome is characterized by secretory diarrhoea, hypokalaemia and achlorhydria.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: El-Khouly F, Khan M, Toumpanakis C, Meyer T, Caplin M,

Keywords: VIPoma, VIPoma syndrome,

#243 Morbidity and Mortality Associated with Desmoplasia in Midgut Neuroendocrine Tumors (NETs)

Introduction: The clinical course of midgut NETs may be heavily complicated by problems related to mesenteric desmoplasia, causing symptoms secondary to mesenteric artery/vein occlusion and bowel obstruction.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: El-Khouly F, Khan M, Toumpanakis C, Ogunbiyi O, Winslet M,

Keywords: midgut, neuroendocrine tumors, desmoplasia,